Provider Briefing: Cepacol Antibacterial Mouthwash Availability in 2026

Cepacol Antibacterial Mouthwash — a Cetylpyridinium Chloride (CPC) 0.05% oral rinse long trusted in hospital settings — has been increasingly difficult for patients to locate at retail pharmacies. As a provider, understanding the current landscape can help you guide patients effectively and adjust recommendations when needed.

This briefing covers the current availability situation, clinical implications, alternative products, and tools you can use to help patients access the oral care they need.

Timeline of Availability Issues

Cepacol Antibacterial Mouthwash has a long history as an OTC oral antiseptic. Here's how availability has evolved:

• Pre-2020: Widely available in 24 oz and 32 oz sizes across major retail chains.
• 2020-2022: Brand ownership transitioned from Combe to Reckitt Benckiser (RB Health). The 32 oz formulation was discontinued.
• 2023-2024: Intermittent stockouts reported at Walgreens, CVS, and Walmart. Reduced retail shelf allocation observed nationwide.
• 2025-2026: The 24 oz bottle remains in production (DailyMed label updated December 2025, marketing end date September 2027). However, availability remains inconsistent at brick-and-mortar retailers.

Importantly, Cepacol Antibacterial Mouthwash is not on the FDA drug shortage list because it is marketed under an OTC monograph rather than an NDA or ANDA.

Prescribing and Recommendation Implications

For dental and primary care providers who routinely recommend Cepacol Antibacterial Mouthwash — particularly in hospital discharge protocols and post-procedural oral care — the availability challenges have practical implications:

• Hospital formularies: Facilities that include Cepacol in their oral care protocols should verify supply with their distributor and identify backup products.
• Patient recommendations: Patients who have been told to use Cepacol specifically may be frustrated when they can't find it. Proactively discussing alternatives during the visit saves time and patient anxiety.
• Specificity of recommendation: Consider recommending by active ingredient (CPC 0.05% or higher) rather than brand name, giving patients more flexibility at the pharmacy.

Current Availability Picture

Based on retail and online monitoring:

• Walgreens: Stocked online at ~$8.29/24 oz; in-store availability varies by location
• Walmart: Listed at Walmart.com; in-store availability inconsistent
• Amazon: Generally available, including multi-packs; $6-$10 per bottle
• CVS: Intermittently stocked; some locations have dropped the product
• Independent pharmacies: May carry or special-order through wholesale distributors

Providers can direct patients to Medfinder for Providers to help locate products efficiently.

Cost and Access Considerations

Cepacol Antibacterial Mouthwash pricing remains accessible:

• Cash price: $6 to $10 for 24 oz (710 mL)
• Insurance: Not typically covered as an OTC product; no prior authorization or step therapy applies
• FSA/HSA: May be eligible for reimbursement under some plans
• Patient assistance: Not applicable — no formal programs exist for this OTC product

Cost is unlikely to be a barrier for most patients. The primary access issue is physical availability at retail locations.

Store-Brand Alternatives

For cost-sensitive patients, store-brand CPC mouthwashes are available for $3 to $6 at Walmart (Equate) and Target (Up&Up). Verify the CPC concentration is at or above the therapeutic threshold of 0.045%.

Tools and Resources for Providers

Several resources can support your practice:

• Medfinder for Providers: Real-time product availability search to help patients locate medications and OTC products
• DailyMed: Current labeling for Cepacol Antibacterial Mouthwash (NDC 63824-790-80), updated December 2025
• FDA OTC Monograph: CPC is recognized as safe and effective at 0.025% to 0.1% for short-term OTC oral antiseptic use

For clinical decision support on alternatives, our patient-facing guide on alternatives to Cepacol Antibacterial Mouthwash can be shared with patients.

Looking Ahead

The current DailyMed listing shows a marketing end date of September 3, 2027, suggesting RB Health intends to continue production for at least the near term. However, given the trend of reduced retail presence, providers should be prepared for ongoing inconsistency in availability.

Key recommendations for your practice:

1. Recommend CPC mouthwashes by active ingredient rather than brand name when possible
2. Maintain awareness of at least 2-3 CPC or antiseptic mouthwash alternatives to recommend
3. Direct patients to Medfinder for real-time availability checking
4. Update hospital and practice formularies to include backup CPC products
5. For advanced periodontal cases where CPC is insufficient, consider prescribing Chlorhexidine Gluconate 0.12%

Final Thoughts

Cepacol Antibacterial Mouthwash remains a clinically sound product with a well-established safety profile. The access challenges are logistical, not clinical. By guiding patients toward equivalent CPC products and leveraging tools like Medfinder for Providers, you can ensure continuity of care regardless of Cepacol's retail availability.

For additional resources, see our provider-focused guide on helping patients find Cepacol Antibacterial Mouthwash in stock and our guide on helping patients save money on Cepacol.